🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This 6-month prospective outcomes study addresses the association between t...
Status
Completed
Location
Orthopaedic Hospital DBA Orthopaedic Hemophilia Treatment Center
Start Date
2014-07-22
Trial ID
NCT02190149
Treatments Being Tested
Hemophilia A (HA) and hemophilia B (HB) are inherited bleeding disorders ca...
Status
Terminated
Location
The Bleeding and Clotting Disorders Institute
Start Date
2009-10-14
Trial ID
NCT00947193
Treatments Being Tested
Uncontrolled hemorrhage continues to be a significant source of mortality f...
Status
Unknown
Location
Multiple Locations
Start Date
2020-01
Trial ID
NCT03981484
Treatments Being Tested
Study B7841007 is an open-label extension study to assess the long-term saf...
Status
Recruiting
Location
University of Iowa
Start Date
2021-11-17
Trial ID
NCT05145127
Treatments Being Tested
A multicenter, open, non-randomized, phase I/II, two-phase clinical study. ...
Status
Unknown
Location
Shanghai Vitalgen Biopharma Co.,Ltd.
Start Date
2022-07
Trial ID
NCT05441553
Treatments Being Tested
This study is comparing the use of Kcentra vs. standard transfusion in pati...
Status
Terminated
Location
University of Maryland
Start Date
2018-07-11
Trial ID
NCT03341156
Treatments Being Tested
The purpose of this research is to understand if the medication called FEIB...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10
Trial ID
NCT05020483
This is a randomized, open label, placebo-controlled, parallel design, sing...
Status
Completed
Location
PRA Health Sciences
Start Date
2021-11-12
Trial ID
NCT05205863
Treatments Being Tested
This study aims to assess a fixed-dose regimen of activated prothrombin com...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02565836
To demonstrate that the efficacy of OCTAPLEX as a reversal agent in patient...
Status
Completed
Location
Octapharma Research Site
Start Date
2017-06-08
Trial ID
NCT02740335
Treatments Being Tested